 |
 |
 |
 |
Pro-inflammatory Cytokines Levels in saliva/serum of TMJ pain patients
W.R. BOWLES, S.L. MYERS, A.M. VELLY, S. KAIMAL, P.L. CARLSON, D. SOTILLO, J. SPRINGSTEEN, W. KANG, J. SWIFT, and J. FRICTON, University of Minnesota, Minneapolis, USA | Objective: Cytokines can modulate the host
response to infection, injury, inflammation, and bone remodeling. Plasma levels of pro-inflammatory
cytokines have been correlated with TMJ bone loss and progression of disease in
patients with TMJ rheumatoid arthritis. Thus, identification of cytokine
profiles in sera and saliva that have a high correlation with symptoms may
provide new targets for treating patients diagnosed with TMJD. Methods:
The levels of
selected cytokines from saliva and serum were measured in 34 male and female
patients with or without TMJD from different age groups. Multiple cytokines of
interest were measured using microsphere sets coupled with specific capture
antibodies and subjected to multianalyte profiling. Results:
Salivary levels
of IL-1b were significantly higher in TMJD
patients compared to a non-TMJD healthy controls (979.6 vs. 330.7 pg/ml) as
were those for IL-6 (20.3 vs 2.3 pg/ml), with no significant differences seen
in serum levels. For levels of IL-8
and TNFa, no significant differences were noted in saliva, but higher
levels within the sera were seen in TMJD patients for IL-8 (174.2 vs. 25.8
pg/ml) and for TNFa (9.3 vs. 3.0 pg/ml), particularly
in female TMJD patients in the 45-65 year old group who showed a 4- to 7-fold
increase in these two pro-inflammatory cytokines compared to male and female
control groups or male TMJD patients.
In examining levels of the anti-inflammatory cytokine IL-4, salivary levels
were similar between TMJD and control patients, but sera levels of IL-4 were
only detectable in male control patients. Conclusions: Cytokine levels in TMJD can be
altered in serum and saliva from patients with TMJ pain. The role of pro-inflammatory and
anti-inflammatory cytokines need to be further evaluated to document their
sensitivity and specificity in distinguishing TMJD with and without co-morbid
conditions from symptomatic TMJD subtypes as well as from non-TMJD controls. Supported
by NIDCR/N01-DE-22635.
|
Seq #36 - Neuroscience/TMJ 9:45 AM-11:15 AM, Thursday, April 3, 2008 Hilton Anatole Hotel Senators Lecture Hall |
Back to the Neuroscience / TMJ Program
|
|